Newsweek's No. 1 hospital in Southern Malaysia for 2 consecutive years, Ranked for cancer care, cardiac surgery, kidney transplant, and 47 specialties
Mahkota Medical Centre in Melaka has built its reputation through specific clinical achievements that most hospitals in Southeast Asia have not reached: the world's only JCI-certified Chronic Kidney Disease programme, Malaysia's first JCI-certified Breast Cancer Clinical Care Programme, and Southeast Asia's first Tomotherapy Radixact X7 radiotherapy system.
Every year, international patients from 10+ countries choose Mahkota for treatment - from Indonesia, Singapore, Bangladesh, Cambodia, Brunei, and beyond.
They come because of the clinical outcomes, but many stay because of what surrounds them: 19 authorised representative offices across the region, coordinators who speak Bahasa Indonesia, Mandarin, and English, free airport transfers, and a system designed so that from your first enquiry, your entire journey is mapped out before you board a flight.
Melaka is an easy choice logistically as well as clinically. The city sits 1.5 hours from Kuala Lumpur International Airport and is accessible from Singapore by road in under 3 hours. In 32 years of treating patients from across Asia, Mahkota has performed 2,000+ orthopaedic surgeries annually, 8,500+ cardiac procedures over five years, and achieved a 100% kidney transplant success rate - including ABO-incompatible cases. These are not aspirational targets. They are what patients experience when they arrive.